The webpage from Renatus Clinic (https://renatusclinic.jp/tokyo-japan-filler/) provides detailed information about their hyaluronic acid injections services in Tokyo, Japan. Here's an English translation of the key points from the page:

 

 

1. Five Reasons Why Renatus Clinic in Tokyo, Japan is Chosen:

  • English-Speaking Staff: The clinic accommodates English-speaking clients.
  • International Patient Base: Patients from various countries, including the United States, Europe, China, and Australia.
  • Highly Skilled Physicians: Physicians are internal trainers for Allergan, a renowned hyaluronic acid company.
  • Reasonable Pricing: Affordable treatments with genuine Allergan products.
  • Diverse Treatment Areas: Wide range of treatment areas, similar to those offered in New York or Hollywood.

2. The Quality of Hyaluronic Acid Products:

  • Uses Juvederm series by Allergan, approved by the Japanese Ministry of Health, Labour and Welfare.
  • Features Vycross technology for long-lasting effects, appropriate lifting power, low water absorption, high malleability, and excellent tissue compatibility.

3. Various Types of Hyaluronic Acid:

  • Different options based on firmness, duration of effects, and cost.
  • Products like Volux, Voluma, and Diamond Fill are offered, each with different characteristics.

4. The Difference Compared to Low-Cost Clinics:

  • High-quality control, genuine Allergan products, skilled physicians, and safety measures.
  • Warning against the risks of using cheap products.

5. Hyaluronic Acid Injections Treatment Flow:

  • Includes consultation, filler injection procedure details, and post-treatment care.
  • Options for anesthesia and minimal downtime post-treatment.

6. Frequently Asked Questions:

  • Addresses common queries like same-day treatment, pain during the procedure, post-treatment expectations, and specific treatment amounts for different areas.

The clinic focuses on providing high-quality, safe, and diverse hyaluronic acid treatments with skilled staff and a broad international patient base.